Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Revista
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
FEBS J ; 273(10): 2232-43, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16649999

RESUMO

Several studies have shown that deficient uptake or excessive break down of membrane phospholipids may be associated with neurodegenerative and psychiatric disorders. The purpose of the present study was to examine the effects of postnatal iron administration in lipid composition and behavior and whether or not the established effects may be altered by subchronic administration of the neuroleptic compounds, clozapine and haloperidol. In addition to motor activities such as locomotion, rearing and activity, a targeted lipidomics approach has been used to investigated the brains of eight groups of mice (four vehicle groups and four iron groups) containing six individuals in each group treated with vehicle, low dose clozapine, high dose clozapine and haloperidol. Lipids were extracted by the Folch method and analyzed using reversed-phase capillary liquid chromatography coupled on-line to electrospray ionization mass spectrometry (LC/ESI/MS). Identification of phosphatidylcholine (PC) and sphingomyelin (SM) molecular species was based on their retention time, m/z ratio, head group specific up-front fragmentation and analysis of the product ions produced upon fragmentation. A comparison between the Ve-groups and Fe-groups showed that levels of PC and SM molecular species and motor activities were significantly lower in Fe-Ve compared to Ve-Ve. The effects of neuroleptic treatment with and without iron supplementation were studied. In conclusion our results support the hypothesis that an association between psychiatric disorders and lipid and behavior abnormalities in the brain exists.


Assuntos
Antipsicóticos/farmacologia , Química Encefálica/efeitos dos fármacos , Encéfalo/metabolismo , Ferro/farmacologia , Lipídeos de Membrana/química , Atividade Motora/efeitos dos fármacos , Animais , Encéfalo/efeitos dos fármacos , Clozapina/farmacologia , Suplementos Nutricionais , Esquema de Medicação , Feminino , Haloperidol/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Fosfatidilcolinas/química , Gravidez , Esfingomielinas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA